OXFORD BIOMEDICA LS-,50/ GB00BDFBVT43 /
2024-06-03 8:14:16 AM | Chg. -0.040 | Volume | Bid5:35:13 PM | Ask5:35:13 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
3.660EUR | -1.08% | - Turnover: - |
3.800Bid Size: 800 | 4.040Ask Size: 800 | 316.98 mill.EUR | - | - |
Assets
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 4.1000 | 8.9000 | 24.4000 | 27.5000 | 25.4000 | ||||||
Intangible Assets | 2.6000 | 2.1000 | 1.7000 | 1.3000 | .1000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | .7000 | 1.4000 | 2.7000 | 2.2000 | 3.3000 | ||||||
Accounts Receivable | 1 | 3.6000 | 7.4000 | 2 | 5.7000 | ||||||
Cash and Cash Equivalents | 2.2000 | 14.2000 | 9.4000 | 15.3000 | 14.3000 | ||||||
Current Assets | 6.9000 | 22.8000 | 25.7000 | 27.4000 | 37 | ||||||
Total Assets | 13.6000 | 33.9000 | 51.9000 | 56.9000 | 65.4000 |
Liabilities
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1.2000 | 2.8000 | 3.6000 | 1.6000 | 8.7000 | ||||||
Long-term debt | - | 1 | 27.3000 | 34.4000 | 36.9000 | ||||||
Liabilities to Banks | 0.0000 | 1 | 27.3000 | 34.4000 | 36.9000 | ||||||
Provisions | .5000 | .5000 | 1.3000 | .6000 | .6000 | ||||||
Liabilities | 4.7000 | 10.8000 | 41 | 44.3000 | 59.3000 | ||||||
Share Capital | 14.2000 | 25.6590 | 25.7410 | 30.8790 | 31.0760 | ||||||
Total Equity | 8.9000 | 23 | 10.9000 | 12.6000 | 6.1000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 13.6000 | 33.9000 | 51.9000 | 56.9000 | 65.4000 |
Income Statement
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5.4000 | 13.6000 | 15.9000 | 27.8000 | 37.6000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -12.8000 | -10.6000 | -14.1000 | -11.3000 | -5.7000 | ||||||
Interest Income | .0600 | -.1500 | -2.8700 | -8.9700 | -6.0600 | ||||||
Income Before Taxes | -12.8000 | -10.8000 | -17 | -20.3000 | -11.8000 | ||||||
Income Taxes | -1.7000 | -2.1000 | -4 | -3.7000 | -2.7000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -11.1000 | -8.7000 | -13 | -16.6000 | -9 |
Per Share
Cash Flow
|
2013 IFRS in mill. GBP |
2014 IFRS in mill. GBP |
2015 IFRS in mill. GBP |
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -11 | -6 | -13.1000 | -5.1000 | 3 | ||||||
Cash Flow from Investing Activities | 4.2000 | -5.5000 | -16.7000 | -6.4000 | -1.9000 | ||||||
Cash Flow from Financing | 0.0000 | 23.6000 | 25 | 17.5000 | -2.1000 | ||||||
Decrease / Increase in Cash | -6.8000 | 12 | -4.8000 | 6 | -1 | ||||||
Employees | 106 | 134 | 231 | 256 | 321 |